BioAtla (BCAB) Total Current Liabilities (2020 - 2026)

BioAtla (BCAB) has reported Total Current Liabilities for 7 consecutive years, with $21.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Current Liabilities rose 26.63% year-over-year to $21.0 million; the trailing twelve-month figure through Jun 2026 stood at $21.0 million (up 26.63% YoY), and the FY2025 full-year result was $21.9 million, up 50.77% from the prior year.
• Total Current Liabilities improved to $21.0 million in Q2 2026 per BCAB's latest filing, from $20.7 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $35.6 million in Q3 2023 and bottomed at $14.5 million in Q4 2024.
• Historically, Total Current Liabilities has averaged $22.1 million across 5 years, with a median of $20.9 million in 2026.
• The sharpest annual moves came in 2023 and 2024: Total Current Liabilities jumped 52.78% in 2023, then sank 48.7% in 2024.
• Over 5 years, Total Current Liabilities stood at $23.1 million in 2022, then gained by 22.54% to $28.3 million in 2023, then tumbled by 48.7% to $14.5 million in 2024, then surged by 50.77% to $21.9 million in 2025, then retreated by 4.11% to $21.0 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $21.0 million, $20.7 million, and $21.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.